Pierre Fabre wählt AGC Biologics als CDMO zur Herstellung des Orphan Drugs ER-004 ...Middle East

SEATTLE, 22. Dezember 2020 /PRNewswire/ -- AGC Biologics, ein weltweit führendes biopharmazeutisches Auftragsentwicklungs- und Produktionsunternehmen (CDMO), gab seine Partnerschaft mit Laboratoire Pierre Fabre zur Herstellung von ER-004 bekannt - einem intra-amniotischen Medikament, das...

Hence then, the article about pierre fabre wahlt agc biologics als cdmo zur herstellung des orphan drugs er 004 was published today ( Tuesday 22/12/2020 - 05:15 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pierre Fabre wählt AGC Biologics als CDMO zur Herstellung des Orphan Drugs ER-004 )

Also on site :

• Amazon’s 'Light' and ‘Airy' $17 Cotton-Linen Pants Are ‘Perfect for Summer,’ and They Come in 6 Styles
• Watch 'America's Got Talent' Judges Get Blown Away by 'Insane' Tumbling Act That Has Been 67 Years in the Making
• Adam Sandler Reportedly Called the Nantucket Police 48 Hours After Taylor Swift's Wedding — Here’s Why